Main > RHEUMATOLOGY > USA. E. AS>Treat.>IL-17 MAb Inj.

---

USA. E. AS>Treat.>IL-17 MAb Inj.'s subsections
(*) USA Approval Date: 2019. 08.26.
Company
Generic Name: Ixekizumab
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 4
Patent>UpDate: 2021. 10.26.
RTM
RTM Web-Site

USA. E. AS>Treat.>IL-17 MAb Inj.'s products
This section has no products